Literature DB >> 22465003

Do patients with elderly-onset rheumatoid arthritis have severe functional disability?

Soo-Kyung Cho1, Yoon-Kyoung Sung, Chan-Bum Choi, Hoon-Suk Cha, Jung-Yoon Choe, Won Tae Chung, Seung-Jae Hong, Jae-Bum Jun, Jinseok Kim, Tae-Hwan Kim, Tae-Jong Kim, Eun-Mi Koh, Hye-Soon Lee, Jisoo Lee, Shin-Seok Lee, Sung Won Lee, Dae-Hyun Yoo, Bo Young Yoon, Sang-Cheol Bae.   

Abstract

OBJECTIVE: To identify the clinical features of elderly-onset rheumatoid arthritis (EORA) and their impact on disease outcome.
METHODS: A total of 3169 rheumatoid arthritis (RA) patients were recruited as part of the Korean Observational Study Network for Arthritis, the nationwide cohort of South Korea. Patients were stratified according to age at disease onset: <40 years (younger age-onset RA, n = 1167), between the ages of 40 and 59 (middle-aged-onset RA, n = 1516), and ≥60 years (EORA, n = 486). To evaluate the significance of differences in clinical features among these 3 groups, we performed analysis of variance (anova) and the χ(2) test. We used multivariable logistic regression analysis to examine the association of onset age with functional disability measured with Health Assessment Questionnaire-Disability Index (HAQDI).
RESULTS: EORA patients were associated with high HAQDI (≥1) in bivariable analysis [odds ratio (OR) 1.36, confidence interval (CI) 1.04-1.77]. However, in multivariable analysis, not elderly onset but patients' age, female gender, high disease activity, disease duration over 10 years, and comorbidity with cardiovascular disease were associated with high HAQDI. Only in a predefined subgroup with disease duration <10 years, elderly onset was an independent influencing factor for the functional disability of RA patients (OR 3.04, CI 1.85-5.67: disease duration of <5 years, OR 3.07, CI 1.64-5.74: disease duration of 5 to 10 years).
CONCLUSIONS: Disease onset in older age was associated independently with functional disability of RA patients who have relatively short disease duration.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22465003     DOI: 10.1016/j.semarthrit.2012.02.004

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  18 in total

Review 1.  Morning Stiffness in Elderly Patients with Rheumatoid Arthritis: What is Known About the Effect of Biological and Targeted Agents?

Authors:  Chi Chiu Mok
Journal:  Drugs Aging       Date:  2018-06       Impact factor: 3.923

2.  Neighborhood and healthy aging in a German city: distances to green space and senior service centers and their associations with physical constitution, disability, and health-related quality of life.

Authors:  Susanne Vogt; Andreas Mielck; Ursula Berger; Eva Grill; Annette Peters; Angela Döring; Rolf Holle; Ralf Strobl; Anja-Kerstin Zimmermann; Birgit Linkohr; Kathrin Wolf; Klaus Kneißl; Werner Maier
Journal:  Eur J Ageing       Date:  2015-05-14

3.  The incidence of upper and lower extremity surgery for rheumatoid arthritis among Medicare beneficiaries.

Authors:  Jennifer Waljee; Lin Zhong; Onur Baser; Huseyin Yuce; David A Fox; Kevin C Chung
Journal:  J Bone Joint Surg Am       Date:  2015-03-04       Impact factor: 5.284

Review 4.  An autumn tale: geriatric rheumatoid arthritis.

Authors:  Senol Kobak; Cemal Bes
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-11-07       Impact factor: 5.346

Review 5.  Optimizing perioperative outcomes for older patients with rheumatoid arthritis undergoing arthroplasty: emphasis on medication management.

Authors:  Susan M Goodman
Journal:  Drugs Aging       Date:  2015-05       Impact factor: 3.923

Review 6.  Safety and Efficacy of Biological Disease-Modifying Antirheumatic Drugs in Older Rheumatoid Arthritis Patients: Staying the Distance.

Authors:  Alla Ishchenko; Rik J Lories
Journal:  Drugs Aging       Date:  2016-06       Impact factor: 3.923

7.  [Clinical characteristics and risk factors of cardiovascular disease in patients with elderly-onset rheumatoid arthritis: A large cross-sectional clinical study].

Authors:  J L Chen; Y B Jin; Y F Wang; X Y Zhang; J Li; H H Yao; J He; C Li
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2020-12-18

8.  The influence of age at disease onset on disease activity and disability: results from the Ontario Best Practices Research Initiative.

Authors:  T N Ruban; B Jacob; J E Pope; E C Keystone; C Bombardier; B Kuriya
Journal:  Clin Rheumatol       Date:  2015-08-06       Impact factor: 2.980

9.  Studies on ageing and the severity of radiographic joint damage in rheumatoid arthritis.

Authors:  Lukas Mangnus; Hanna W van Steenbergen; Elisabet Lindqvist; Elisabeth Brouwer; Monique Reijnierse; Tom W J Huizinga; Peter K Gregersen; Ewa Berglin; Solbritt Rantapää-Dahlqvist; Désirée van der Heijde; Annette H M van der Helm-van Mil
Journal:  Arthritis Res Ther       Date:  2015-08-24       Impact factor: 5.156

10.  Effectiveness of bazedoxifene in preventing glucocorticoid-induced bone loss in rheumatoid arthritis patients.

Authors:  Soo-Kyung Cho; Hyoungyoung Kim; Jiyoung Lee; Eunwoo Nam; Seunghun Lee; Yun Young Choi; Yoon-Kyoung Sung
Journal:  Arthritis Res Ther       Date:  2021-07-02       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.